Welcome home, fellow Gator.

The Gator Nation's oldest and most active insider community
Join today!
  1. Hi there... Can you please quickly check to make sure your email address is up to date here? Just in case we need to reach out to you or you lose your password. Muchero thanks!

US expects $6 billion savings from first Medicare drug price negotiations

Discussion in 'Too Hot for Swamp Gas' started by G8trGr8t, Aug 15, 2024.

  1. G8trGr8t

    G8trGr8t Premium Member

    32,507
    12,180
    3,693
    Aug 26, 2008
    way past due but the dems should be reminding the public about this and the reduction in cost of insulin etc

    still don't understand why they didn't write it such that all prices could be negotiated instead of a limited number of drugs

    will this also automatically drop the cost of the drugs to the insurance companies?

    US expects $6 billion savings from first Medicare drug price negotiations (msn.com)

    President Joe Biden's signature Inflation Reduction Act, signed into law in 2022, allows Medicare to negotiate prices for some of the most costly drugs that the program covers for 66 million people.

    The new prices will go into effect in 2026. They represent cuts to individual list prices that do not reflect any rebates and discounts the government may already have been getting for the drugs.

    Merck & Co's diabetes drug Januvia faces the steepest percentage price cut of the drugs on the list, decreasing 79%, and the prices of Novo Nordisk's insulin as part products will be slashed by 76%, according to the government. The other eight drugs on the list face cuts of between 68% and 38%.

    The administration said people covered by Medicare, which mostly serves Americans aged 65 and over, would also save $1.5 billion in out-of-pocket costs for the prescription medicines in 2026. They include widely used diabetes treatments Januvia and Jardiance, blood thinners Eliquis and Xarelto and leukemia drug Imbruvica.
     
    • Winner Winner x 2
    • Informative Informative x 1
  2. VAg8r1

    VAg8r1 GC Hall of Fame

    21,504
    1,800
    1,763
    Apr 8, 2007
    Anyone ever wonder why the ban against the government negotiating Medicare drug prices was included in the statute the created Medicare Part D, the Medicare prescription benefit in the first place? The answer is former Representative Billy Tauzin. Tauzin was the Chairman of the Committee that wrote the statute. Shortly after the act was passed Tauzin left Congress and was hired as President and CEO of the Pharmaceutical Research and Manufacturers of America (PhRMA), a pharmaceutical company lobby group. His annual compensation went from $150,000 a year as a member of Congress to an estimated $2 million. Tauzin is one of the best examples that America has the best politicians that money can buy.
     
    • Informative Informative x 3
    • Fistbump/Thanks! Fistbump/Thanks! x 1